CASIA OpenIR  > 中国科学院分子影像重点实验室
Intraoperative molecular imaging clinical trials: a review of 2020 conference proceedings
Azari, Feredun1; Kennedy, Gregory1; Bernstein, Elizabeth1; Hadjipanayis, Constantinos2; Vahrmeijer, Alexander L.3; Smith, Barbara L.4; Rosenthal, Eben5; Sumer, Baran6; Tian, Jie7; Henderson, Eric R.8; Lee, Amy9; Quyen Nguyen10; Gibbs, Summer L.11; Pogue, Brian W.8,12; Orringer, Daniel A.13; Charalampaki, Cleopatra14; Martin, Linda W.15; Tanyi, Janos L.1; Lee, Major Kenneth1; Lee, John Y. K.1; Singhal, Sunil1
Source PublicationJOURNAL OF BIOMEDICAL OPTICS
ISSN1083-3668
2021-05-01
Volume26Issue:5Pages:22
Corresponding AuthorSinghal, Sunil(sunil.singhal@pennmedicine.upenn.edu)
AbstractSignificance: Surgery is often paramount in the management of many solid organ malignancies because optimal resection is a major factor in disease-specific survival. Cancer surgery has multiple challenges including localizing small lesions, ensuring negative surgical margins around a tumor, adequately staging patients by discriminating positive lymph nodes, and identifying potential synchronous cancers. Intraoperative molecular imaging (IMI) is an emerging potential tool proposed to address these issues. IMI is the process of injecting patients with fluorescenttargeted contrast agents that highlight cancer cells prior to surgery. Over the last 5 to 7 years, enormous progress has been achieved in tracer development, near-infrared camera approvals, and clinical trials. Therefore, a second biennial conference was organized at the University of Pennsylvania to gather surgical oncologists, scientists, and experts to discuss new investigative findings in the field. Our review summarizes the discussions from the conference and highlights findings in various clinical and scientific trials. Aim: Recent advances in IMI were presented, and the importance of each clinical trial for surgical oncology was critically assessed. A major focus was to elaborate on the clinical endpoints that were being utilized in IMI trials to advance the respective surgical subspecialties. Approach: Principal investigators presenting at the Perelman School of Medicine Abramson Cancer Center's second clinical trials update on IMI were selected to discuss their clinical trials and endpoints. Results: Multiple phase III, II, and I trials were discussed during the conference. Since the approval of 5-ALA for commercial use in neurosurgical malignancies, multiple tracers and devices have been developed to address common challenges faced by cancer surgeons across numerous specialties. Discussants also presented tracers that are being developed for delineation of normal anatomic structures that can serve as an adjunct during surgical procedures. Conclusions: IMI is increasingly being recognized as an improvement to standard oncologic surgical resections and will likely advance the art of cancer surgery in the coming years. The endpoints in each individual surgical subspecialty are varied depending on how IMI helps each specialty solve their clinical challenges. (C) The Authors. Published by SPIE under a Creative Commons Attribution 4.0 Unported License.
Keywordintraoperative molecular imaging fluorescence-guided surgery tumor surgery optical biopsy intraoperative visualization molecular imaging
DOI10.1117/1.JBO.26.5.050901
WOS KeywordFLUORESCENCE-GUIDED SURGERY ; BREAST-CANCER ; PANITUMUMAB-IRDYE800CW ; RESECTION ; SGM-101 ; FUTURE ; CEA
Indexed BySCI
Language英语
WOS Research AreaBiochemistry & Molecular Biology ; Optics ; Radiology, Nuclear Medicine & Medical Imaging
WOS SubjectBiochemical Research Methods ; Optics ; Radiology, Nuclear Medicine & Medical Imaging
WOS IDWOS:000657333600001
PublisherSPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
Citation statistics
Cited Times:2[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttp://ir.ia.ac.cn/handle/173211/45326
Collection中国科学院分子影像重点实验室
Corresponding AuthorSinghal, Sunil
Affiliation1.Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
2.Icahn Sch Med Mt Sinai, New York, NY USA
3.Leiden Univ, Med Ctr, Leiden, Netherlands
4.Harvard Univ, Sch Med, Boston, MA USA
5.Stanford Univ, Sch Med, Stanford, CA USA
6.Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
7.Chinese Acad Sci, Inst Automat, Beijing, Peoples R China
8.Dartmouth Coll, Geisel Sch Med, Hanover, NH USA
9.Univ Washington, Sch Med, Seattle, WA USA
10.Univ Calif San Diego, Sch Med, San Diego, CA USA
11.Oregon Hlth & Sci Univ, Sch Med, Knight Canc Inst, Portland, OR USA
12.Thayer Sch Engn Dartmouth, Hanover, NH USA
13.Univ Michigan, Ann Arbor, MI 48109 USA
14.Cologne Med Ctr, Cologne, Germany
15.Univ Virginia, Sch Med, Charlottesville, VA 22908 USA
Recommended Citation
GB/T 7714
Azari, Feredun,Kennedy, Gregory,Bernstein, Elizabeth,et al. Intraoperative molecular imaging clinical trials: a review of 2020 conference proceedings[J]. JOURNAL OF BIOMEDICAL OPTICS,2021,26(5):22.
APA Azari, Feredun.,Kennedy, Gregory.,Bernstein, Elizabeth.,Hadjipanayis, Constantinos.,Vahrmeijer, Alexander L..,...&Singhal, Sunil.(2021).Intraoperative molecular imaging clinical trials: a review of 2020 conference proceedings.JOURNAL OF BIOMEDICAL OPTICS,26(5),22.
MLA Azari, Feredun,et al."Intraoperative molecular imaging clinical trials: a review of 2020 conference proceedings".JOURNAL OF BIOMEDICAL OPTICS 26.5(2021):22.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Azari, Feredun]'s Articles
[Kennedy, Gregory]'s Articles
[Bernstein, Elizabeth]'s Articles
Baidu academic
Similar articles in Baidu academic
[Azari, Feredun]'s Articles
[Kennedy, Gregory]'s Articles
[Bernstein, Elizabeth]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Azari, Feredun]'s Articles
[Kennedy, Gregory]'s Articles
[Bernstein, Elizabeth]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.